Showing results (2731-2740 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|October 5, 1995
The cost effectiveness of Helicobacter pylori eradication versus maintenance and episodic treatment in duodenal ulcer patients in SwedenP Unge, B Jönsson, N O StålhammarPharmacoeconomics|December 9, 1995
A review of the quality-of-life aspects of urinary urge incontinenceW R Lenderking, J F Nackley, R B Anderson, et al.Pharmacoeconomics|December 9, 1995
Costs of insulin-dependent diabetes mellitusT T Simell, H Sintonen, J Hahl, et al.Pharmacoeconomics|December 9, 1995
Switching the histamine H2 receptor antagonist famotidine to nonprescription status in Canada. An economic evaluationR F Tasch, R Goeree, C J Henke, et al.Pharmacoeconomics|March 8, 1996
Do physicians' perceptions of drug costs influence their prescribing?M Ryan, B Yule, C Bond, et al.Pharmacoeconomics|March 8, 1996
The economic costs of caring for people with HIV infection and AIDS in England and WalesS Petrou, M Dooley, L Whitaker, et al.Pharmacoeconomics|March 8, 1996
The November 1995 revised Australian guidelines for the economic evaluation of pharmaceuticalsP C LangleyPharmacoeconomics|March 8, 1996
Granisetron. A pharmacoeconomic evaluation of its use in the prophylaxis of chemotherapy-induced nausea and vomitingG L Plosker, P BenfieldPharmacoeconomics|April 7, 1997
Cost considerations in the pharmacological prevention and treatment of strokeA V Alexandrov, L T Smurawska, W Bartle, et al.Pharmacoeconomics|April 7, 1997
Constraints on antidepressant prescribing and principles of cost-effective antidepressant use. Part 1: Depression and its treatmentJ A Henry, C A RivasPageof 336